ROYCE & ASSOCIATES LP 13D/13G Filings for OptimizeRx Corporation (OPRX)

ROYCE & ASSOCIATES LP 13D and 13G filings for OptimizeRx Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-07-16
11:35 am
Sale
2025-06-3013GOptimizeRx Corporation
OPRX
ROYCE & ASSOCIATES LP790,640
4.270%
-278,920decrease
(-26.08%)
Filing
2025-01-28
12:58 pm
Purchase
2024-12-3113GOptimizeRx Corporation
OPRX
ROYCE & ASSOCIATES LP1,069,560
5.810%
1,069,560increase
(New Position)
Filing